1
|
Li H, Zhao L, Liang Z, Wang Z, Hu C, Wang Y, Shen G, Wang S. Identification of Xuanfei Baidu granule constituents by liquid chromatography-quadruple-time-of-flight-mass spectrometry and its anti-inflammatory active constituents using a lipopolysaccharide-induced RAW264.7 cell model. Biomed Chromatogr 2024; 38:e5898. [PMID: 38802724 DOI: 10.1002/bmc.5898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2024] [Revised: 04/14/2024] [Accepted: 05/07/2024] [Indexed: 05/29/2024]
Abstract
The Xuanfei Baidu (XFBD) prescription, a traditional Chinese medicine prescription, has demonstrated significant anti-inflammatory activities; however, the number of its reported constituents is limited, and its anti-inflammatory constituents are unclear. In this study, the constituents of XFBD granule, a granule dosage of XFBD prescription, were thoroughly examined in vitro and in vivo using liquid chromatography-quadruple-time-of-flight-mass spectrometry, and the anti-inflammatory constituents were screened. A total of 214 constituents were identified from the XFBD granule, 62 of which were confirmed via comparison with reference standards. After intragastric administration of XFBD granule, 63 and 28 constituents were absorbed into the rat sera and lungs in prototype form, respectively. XFBD granule and XFBD-containing serum were found to significantly reduce nitric oxide (NO) and interleukin-6 (IL-6) secretion in lipopolysaccharide-induced RAW264.7 cells. Five anti-inflammatory constituents (verbasoside, scutellarin, luteolin, apigenin, and pogostone) were found to reduce the concentration of NO and IL-6 in a dose-dependent manner. Moreover, the combination of these five constituents could significantly reduce NO secretion even when the concentration of each constituent was two to three orders of magnitude lower than their individual minimum effective concentrations. Overall, this study provides a valuable reference for the discovery of effective constituents from the XFBD granule.
Collapse
Affiliation(s)
- Haoran Li
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Lu Zhao
- Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Ziqi Liang
- Innovation Center of Translational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua, China
| | - Zhiyan Wang
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Chenxiu Hu
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Yi Wang
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Guofang Shen
- Hangzhou Institute for Food and Drug Control, Hangzhou, China
| | - Shufang Wang
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
- Innovation Center of Translational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua, China
| |
Collapse
|
2
|
Zhang K, Li C, Wu P, Gao X, Feng X, Shen J, Zhang N, Hu X, Wang S, Zhang H, Lv J, Sun J. Mechanisms of Zhixiao Tang on Anti-Inflammatory Multiple Targets and Multiple Components: Metabonomics Combined with Database Mining Technology. J Inflamm Res 2024; 17:4587-4610. [PMID: 39011417 PMCID: PMC11249118 DOI: 10.2147/jir.s463067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Accepted: 06/26/2024] [Indexed: 07/17/2024] Open
Abstract
Purpose Zhixiao Tang (ZXT), a traditional Chinese compound prescription, has been used clinically to treat pneumonia in China. However, the underlying mechanism of ZXT treatment in pneumonia is still unclear. The present study aimed to reveal the potential mechanism of ZXT in pneumonia using a strategy combining metabolomics and network pharmacology. Methods Initially, the chemical compositions were identified by UPLC-QE-Orbitrap-MS, while the prediction of potential signal pathways was performed through network pharmacology. To assess the anti-inflammatory properties of ZXT in the context of pneumonia, models of 16HBE cells induced by LPS and zebrafish induced by CuSO4 were established to measure levels of inflammatory markers and apoptosis. Subsequently, the differential changes of endogenous metabolites in cells caused by ZXT were examined using metabolomics technology, and the molecular docking analysis of key targets was carried out using Autodock Vina software. Ultimately, the validation of the primary pathways and targets was conducted through quantitative RT-PCR and Western blot techniques. Results A total of 75 compounds were identified through UPLC-QE-Orbitrap-MS analyses. Network pharmacological analysis shows that it plays an anti-inflammatory role in C-type lectin receptor signaling pathway. After ZXT intervention, the inflammatory factors and apoptosis in cells were significantly reduced. Metabonomics analysis showed that 18 metabolites changed significantly. Four key genes were identified, which exhibited partial compatibility with the findings of network pharmacology. Molecular docking analysis confirmed the substantial affinity of the primary targets for ZXT. Furthermore, ZXT exerted a suppressive effect on neutrophil migration, down-regulated the expression of pro-inflammatory cytokine genes, and inhibited the up-regulation of the Dectin-1/SYK/NF-κB signaling pathway. In vivo cell experiments also yielded consistent experimental outcomes. Conclusion This study enhances comprehension of the pharmacological mechanism underlying ZXT's efficacy in pneumonia treatment, thereby establishing a scholarly basis for future research and clinical utilization of ZXT in pneumonia management.
Collapse
Affiliation(s)
- Kaiyue Zhang
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Chunnan Li
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Peitong Wu
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Xiaochen Gao
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Xueqin Feng
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Jiaming Shen
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Nanxi Zhang
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Xuesheng Hu
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Shuo Wang
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Hui Zhang
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Jingwei Lv
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| | - Jiaming Sun
- Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China
| |
Collapse
|
3
|
Li Q, Bai J, Ma Y, Sun Y, Zhou W, Wang Z, Zhou Z, Wang Z, Chen Y, Abliz Z. Pharmacometabolomics and mass spectrometry imaging approach to reveal the neurochemical mechanisms of Polygala tenuifolia. J Pharm Anal 2024; 14:100973. [PMID: 39175609 PMCID: PMC11340588 DOI: 10.1016/j.jpha.2024.100973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2023] [Revised: 03/02/2024] [Accepted: 03/25/2024] [Indexed: 08/24/2024] Open
Abstract
Polygala tenuifolia, commonly known as Yuanzhi (YZ) in Chinese, has been shown to possess anti-insomnia properties. However, the material basis and the mechanism underlying its sedative-hypnotic effects remain unclear. Herein, we investigated the active components and neurochemical mechanism of YZ extracts using liquid chromatography tandem mass spectrometry (LC-MS/MS)-based pharmacometabolomics and mass spectrometry imaging (MSI)-based spatial resolved metabolomics. According to the results, 17 prototypes out of 101 ingredients in the YZ extract were detected in both the plasma and brain, which might be the major components contributing to the sedative-hypnotic effects. Network pharmacology analysis revealed that these prototypes may exert their effects through neuroactive ligand-receptor interaction, serotonergic synapse, dopaminergic synapse, and dopaminergic synapse, among other pathways. LC-MS/MS-based targeted metabolomics and Western blot (WB) revealed that tryptophan-serotonin-melatonin (Trp-5-HT-Mel) and tyrosine-norepinephrine-adrenaline (Tyr-Ne-Ad) are the key regulated pathways. Dopa decarboxylase (DDC) upregulation and phenylethanolamine N-methyltransferase (PNMT) downregulation further confirmed these pathways. Furthermore, MSI-based spatially resolved metabolomics revealed notable alterations in 5-HT in the pineal gland (PG), and Ad in the brainstem, including the middle brain (MB), pons (PN), and hypothalamus (HY). In summary, this study illustrates the efficacy of an integrated multidimensional metabolomics approach in unraveling the sedative-hypnotic effects and neurochemical mechanisms of a Chinese herbal medicine, YZ.
Collapse
Affiliation(s)
- Qian Li
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, 100081, China
| | - Jinpeng Bai
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
| | - Yuxue Ma
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, 100081, China
| | - Yu Sun
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
| | - Wenbin Zhou
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, 100081, China
| | - Zhaoying Wang
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
| | - Zhi Zhou
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
| | - Zhonghua Wang
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
| | - Yanhua Chen
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
| | - Zeper Abliz
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (National Ethnic Affairs Commission), Minzu University of China, Beijing, 100081, China
- Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, 100081, China
- Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100050, China
| |
Collapse
|
4
|
Zhang LB, Yan Y, Ma R, Li DX, Yin WF, Tao QW, Xu Y. Integrated phytochemistry and network pharmacology analysis to reveal effective substances and mechanisms of Bushen Quhan Zhiwang decoction in the treatment of rheumatoid arthritis. JOURNAL OF ETHNOPHARMACOLOGY 2024; 325:117897. [PMID: 38336180 DOI: 10.1016/j.jep.2024.117897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 01/28/2024] [Accepted: 02/06/2024] [Indexed: 02/12/2024]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Bushen Quhan Zhiwang decoction (BQZD), a formula in traditional Chinese medicine (TCM), effectively delays bone destruction in rheumatoid arthritis (RA) patients. However, its chemical constituents, absorbed components, and metabolites remain unrevealed, and its mechanism in treating bone destruction in RA needs further investigation. AIM OF THE STUDY Our objective is to identify the chemical constituents, absorbed components, and metabolites of BQZD and explore the potential mechanisms of BQZD in treating bone destruction in RA. MATERIALS AND METHODS This study systematically identified the chemical constituents, absorbed components, and metabolites of BQZD using ultra-performance liquid chromatography with Q-Exactive Orbitrap mass spectrometry combined with parallel reaction monitoring. The absorbed components and metabolites were subjected to network pharmacology analysis to predict the potential mechanisms of BQZD in treating bone destruction in RA. The in vivo anti-osteoclastogenic and underlying mechanism were further verified in collagen-induced arthritis (CIA) rats. RESULTS A total of 182 compounds were identified in BQZD, 27 of which were absorbed into plasma and organs and 42 metabolites were identified in plasma and organs. The KEGG analysis revealed that MAPK signaling pathway was highly prioritized. BQZD treatment attenuated paw swelling and the arthritis index; suppressed synovial hyperplasia, bone destruction, and osteoclast differentiation; and inhibited the levels of TNF-α, IL-1β, and IL-6 in CIA rats. Mechanically, BQZD significantly decreased the protein expression levels of TRAF6, NFATc1, p-JNK, and p-p38, which might be related to 9 absorbed components and 1 metabolite. CONCLUSION This study revealed the key active components and metabolites of BQZD. BQZD exhibits bone-protective effects via TRAF6/p38/JNK MAPK pathway, which may be associated with 9 absorbed components and 1 metabolite.
Collapse
Affiliation(s)
- Liu-Bo Zhang
- Beijing University of Chinese Medicine, Beijing, 100029, PR China
| | - Yu Yan
- Department of TCM Rheumatism, Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, PR China
| | - Ru Ma
- Clinical Pharmacy Department & Xi'an Public Health Center, Xi'an, 710200, PR China
| | - Dong-Xu Li
- Shenyang Pharmaceutical University, Shenyang, PR China
| | - Wei-Feng Yin
- Beijing University of Chinese Medicine, Beijing, 100029, PR China
| | - Qing-Wen Tao
- Department of TCM Rheumatism, Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, PR China.
| | - Yuan Xu
- Department of TCM Rheumatism, Department of Pharmacy, China-Japan Friendship Hospital, Beijing, 100029, PR China.
| |
Collapse
|
5
|
Zhao Y, Cai X, Sun J, Bi W, Yu Y. Active components and mechanisms of total flavonoids from Rhizoma Drynariae in enhancing cranial bone regeneration: An investigation employing serum pharmacochemistry and network pharmacology approaches. JOURNAL OF ETHNOPHARMACOLOGY 2024; 319:117253. [PMID: 37778522 DOI: 10.1016/j.jep.2023.117253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 09/25/2023] [Accepted: 09/28/2023] [Indexed: 10/03/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Rhizoma Drynariae, as the dried rhizome of Drynaria fortunei (Kunze ex Mett.) J. Sm., is a traditional Chinese medicine for treating the injury and bone broken of falling and beating. Total flavonoids is considered as the major and effective compounds for the therapeutic efficacy of Rhizoma Drynariae. AIM OF THE STUDY To explore the effect of total flavonoids from Rhizoma Drynariae (TFRD) on bone regeneration and the underlying mechanisms. MATERIALS AND METHODS The effect of TFRD in various doses on bone reconstruction in cranial bone defect rats was explored in vivo. The active ingredients in TFRD-medicated serum were characterized by serum pharmacochemistry and integrated by network pharmacology analysis and target prediction. To elucidate the underlying mechanism of TFRD on bone regeneration, experimental validation in vitro was executed to assess the influence of different concentrations of TFRD-medicated serum on osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). RESULTS Micro-CT, histological examination, immunohistochemical analysis, and ELSA demonstrated that administration of TFRD could promote bone reconstruction in a rat cranial defect model. We identified 27 active components of TFRD using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS). Results from CCK8, ALP, and Alizarin Red S staining revealed that TFRD-medicated serum notably enhanced BMSCs proliferation and osteogenic differentiation. qRT-PCR and Western blot harvested results consistent with those predicted by network pharmacology, providing further evidence that TFRD activated the TGF-β signaling pathway to benefit bone regeneration. CONCLUSION The active components of TFRD modulate the TGF-β signaling pathway to facilitate osteogenesis, thereby repairing cranial bone defects.
Collapse
Affiliation(s)
- Yuxiao Zhao
- Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China
| | - Xiaofang Cai
- Department of Stomatology, Minhang Hospital, Fudan University, No. 170 Xinsong Road, Shanghai, 201199, PR China
| | - Jian Sun
- Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China
| | - Wei Bi
- Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China
| | - Youcheng Yu
- Department of Stomatology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, PR China.
| |
Collapse
|
6
|
Nong Y, Zhang C, Guo Y, Qin Y, Zhong X, Feng L, Pan Z, Deng L, Guo H, Su Z. Quality control for a traditional Chinese medicine, Millettia speciosa Champ, using ultra-high-performance liquid chromatography fingerprint, serum pharmacochemistry and network pharmacology. ANALYTICAL METHODS : ADVANCING METHODS AND APPLICATIONS 2023; 15:5166-5180. [PMID: 37753596 DOI: 10.1039/d3ay01051a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/28/2023]
Abstract
Millettia speciosa (M. speciosa) Champ (MSC) is a healthy food type with medicinal and edible homology, which is now considered a clinically significant anti-rheumatoid arthritis medicine. However, there is currently no standardized or generally accepted research strategy by which we can assess M. speciosa. Thus, it is essential to develop novel theories, strategies and evaluation methods for the scientific quality control of M. speciosa. Herein, our use ultra-high-performance liquid chromatography (UPLC)-MS/MS analysis identified 12 common bioactive components absorbed into MSC serum. Next, network pharmacology analysis exhibited that 5 MSC components may be those active components in treating rheumatoid arthritis and may be considered potential quality markers. These 5 components were then quantified using a fast UPLC approach, based on the quality marker of measurability, showing that lenticin can be regarded as the MSC quality marker. The cumulative study findings, based on systematic assessment of chemical composition both in vivo and in vitro, and the potential efficacy of M. speciosa, provide a novel approach for M. speciosa quality control.
Collapse
Affiliation(s)
- Yunyuan Nong
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Chi Zhang
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Yue Guo
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
- Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Traditional Medical and Pharmaceutical Sciences, Nanning, Guangxi, 530022, China
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Yuelian Qin
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Xinyu Zhong
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Linlin Feng
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Ziping Pan
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Lijun Deng
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
| | - Hongwei Guo
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
- Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Medical University, Nanning, Guangxi, 530021, China
| | - Zhiheng Su
- Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, China.
- Guangxi Beibu Gulf Marine Biomedicine Precision Development and High-value Utilization Engineering Research Center, Guangxi Medical University, Nanning, Guangxi, 530021, China
- Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Medical University, Nanning, Guangxi, 530021, China
- Guangxi Health Commission Key Laboratory of Basic Research on Antigeriatric Drugs, Guangxi Medical University, Nanning, Guangxi, 530021, China
| |
Collapse
|
7
|
Li R, Zhu L, Wu M, Tao C, Lu Y, Zhao Y, Jiang X, Zhang C, Wan L. Serum Pharmacochemistry Combined with Network Pharmacology-Based Mechanism Prediction and Pharmacological Validation of Zhenwu Decoction on Alleviating Isoprenaline-Induced Heart Failure Injury in Rats. ACS OMEGA 2023; 8:37233-37247. [PMID: 37841161 PMCID: PMC10568591 DOI: 10.1021/acsomega.3c05055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Accepted: 09/13/2023] [Indexed: 10/17/2023]
Abstract
Zhenwu decoction (ZWD) is a famous classical formula in the treatment of heart failure (HF) with significant clinical effects. Owing to the complex material basis of ZWD, it is challenging to elucidate the pharmacodynamic substances and pharmacological mechanisms of ZWD against HF. Therefore, an ultrahigh-performance liquid chromatography system coupled with a high-resolution orbitrap mass spectrometry method was used to profile the chemical components and the absorbed prototype constituents in ISO-induced HF rat serum after oral administration of ZWD, and 33 out of 115 compounds were identified. In the in vivo study, ZWD could improve cardiac function and reduce the content of serum biochemical indexes, which are heart failure markers. With the help of network pharmacology and molecular docking simulation analysis, 112 ZWD targets oriented by HF were obtained, with STAT3, TNF, AKT1, VEGFA, and ALB as the core targets. Furthermore, we found that paeoniflorin and its derivatives may play a bigger role than other serum migrant components. Enriched pathway analysis yielded multiple HF-related signaling pathways, which indicated that ZWD may attenuate HF through the effect of PI3K-Akt, and MAPK pathways by regulating key targets such as STAT3, TNF, and AKT1. Finally, STAT3/MAPK pathways were experimentally validated in the anti-HF effect of ZWD. The phosphorylation levels of p38, JNK, ERK, and STAT3 were significantly increased in the ISO group and reversed by ZWD intervention. The results provided a reasonable strategy for the rapid screening of bioactive components in ZWD and a reference for quality control and further mechanism study of ZWD.
Collapse
Affiliation(s)
- Ruiyu Li
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
- Sichuan
Engineering Technology Research Centre for Injection of Traditional
Chinese Medicines, China Resources Sanjiu
(Yaan) Pharmaceutical Co., Ltd., Yaan, Sichuan 625000, P. R. China
| | - Lv Zhu
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
| | - Mengyao Wu
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
| | - Chengtian Tao
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
| | - Yang Lu
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
| | - Yunyan Zhao
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
| | - Xiaofeng Jiang
- Sichuan
Engineering Technology Research Centre for Injection of Traditional
Chinese Medicines, China Resources Sanjiu
(Yaan) Pharmaceutical Co., Ltd., Yaan, Sichuan 625000, P. R. China
| | - Chi Zhang
- Sichuan
Engineering Technology Research Centre for Injection of Traditional
Chinese Medicines, China Resources Sanjiu
(Yaan) Pharmaceutical Co., Ltd., Yaan, Sichuan 625000, P. R. China
| | - Li Wan
- State
Key Laboratory of Southwestern Chinese Medicine Resources, School
of pharmacy, Chengdu University of Traditional
Chinese Medicine, Chengdu, Sichuan 611137, P. R. China
| |
Collapse
|
8
|
Lei X, Xu H, Wang Y, Gao H, Zhao D, Zhang J, Zhu Z, Zuo K, Liu Y, Li X, Zhang N. Integrating Network Pharmacology and Component Analysis to Study the Potential Mechanisms of Qi-Fu-Yin Decoction in Treating Alzheimer's Disease. Drug Des Devel Ther 2023; 17:2841-2858. [PMID: 37727255 PMCID: PMC10506672 DOI: 10.2147/dddt.s402624] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2023] [Accepted: 08/16/2023] [Indexed: 09/21/2023] Open
Abstract
Purpose To elucidate the potential mechanisms of QFY for the treatment of Alzheimer's Disease (AD), and explore the effective substances of QFY. Materials and Methods UPLC-LTQ-Orbitrap-MS was used to identify the chemical constituents of the serum samples and the cerebrospinal fluid samples of rats after QFY administration. Network pharmacology was used to predict potential targets and pathways of QFY against AD. The AD mice model was established by subcutaneous injection of D-gal for 8 consecutive weeks. New object recognition (NOR) and Morris water maze test (MWM) were used to evaluate the learning and memory abilities of mice. Moreover, the levels of TNF-α, IL-1β, and IL-18 in the brain hippocampus of mice were determined by ELISA. The expression of Bax, Bcl-2, Caspase-1, PSD95, SYP, ICAM-1 and MCP-1 proteins in the hippocampus was detected by Western blotting. Furthermore, qRT-PCR was used to detect the gene expressions of PSD95, SYP, M1 and M2 polarization markers of microglia, including iNOS, CD16, ARG-1, and IL-10 in the hippocampus. Results A total of 51 prototype compounds were detected in rat serum and 15 prototype components were identified in rat cerebrospinal fluid. Behavioral experiments revealed that QFY significantly increased the recognition index, decreased the escape latency, increased the platform crossing times and increased the residence time in the target quadrant. QFY also could alleviate the ultrastructural pathological changes in the hippocampus of AD mice. Meanwhile, QFY treatment suppressed the expression of inflammatory factors, such as TNF-α, IL-1β, and IL-18. QFY improved the synaptic plasticity of the hippocampus in D-gal model mice by significantly increasing the expression of proteins and mRNAs of PSD95 and SYP. Conclusion QFY could effectively improve the learning and memory impairment of D-gal-induced AD mice by inhibiting the excessive activation of microglia, enhancing the expression of M2 microglia, inhibiting the increase of inflammatory factors, cell adhesion factors and chemokines, anti-apoptosis, and improving synaptic plasticity.
Collapse
Affiliation(s)
- Xia Lei
- Jiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, 214071, People’s Republic of China
| | - Hongdan Xu
- Department of Pharmacy, Wuxi Higher Health Vocational Technology School, Wuxi, 214000, People’s Republic of China
| | - Yan Wang
- Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Provincial Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Hainan Medical University, Haikou, 571199, People’s Republic of China
| | - Hainan Gao
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, People’s Republic of China
| | - Deping Zhao
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, People’s Republic of China
| | - Jinfeng Zhang
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, People’s Republic of China
| | - Ziyue Zhu
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, People’s Republic of China
| | - Kun Zuo
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, People’s Republic of China
| | - Ying Liu
- Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Provincial Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Hainan Medical University, Haikou, 571199, People’s Republic of China
| | - Xiaoliang Li
- Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Provincial Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Hainan Medical University, Haikou, 571199, People’s Republic of China
- Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province, Cardiovascular Diseases Institute of the First Affiliated Hospital, Hainan Medical University, Haikou, 571199, People’s Republic of China
| | - Ning Zhang
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, People’s Republic of China
| |
Collapse
|
9
|
Wei J, Wang Y, Zhang Y, Zheng Y, Shao J, Cheng W, Li Y. Rapid identification of chemical components in vitro and in vivo of Menispermi Rhizoma by integrating UPLC-Q-TOF-MS with data post-processing strategy. PHYTOCHEMICAL ANALYSIS : PCA 2023; 34:347-362. [PMID: 36823393 DOI: 10.1002/pca.3214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Revised: 01/13/2023] [Accepted: 01/30/2023] [Indexed: 06/18/2023]
Abstract
INTRODUCTION Menispermi Rhizoma (MR), the dried rhizome of Menispermum dauricum DC. (Menispermaceae), has been used to treat sore throat, enteritis, dysentery, and rheumatic arthralgia. Despite extensive research on its pharmacological effects, the chemical components in vitro and in vivo have not been thoroughly studied. OBJECTIVE To establish an efficient method for rapid classification and identification of alkaloids in MR and its preparations, as well as metabolites in vivo after oral administration of MR. METHODS Rapid identification of alkaloids and absorbed components of MR was performed using ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) coupled with UNIFI software. Moreover, the characteristic fragmentations and neutral losses of different types of alkaloids in MR were summarised to realise the rapid classification of alkaloids. RESULTS A total of 55 components were unambiguously or tentatively identified in MR. Among them, 37 and 31 components were found in MR capsules and tablets, respectively. Meanwhile, 109 compounds were tentatively identified in rat plasma, urine and faeces, including 55 prototypes and 54 metabolites. Hydrogenation, hydroxylation, methylation, glucuronic acid and sulphate conjugations were the dominating metabolic fates of alkaloids. CONCLUSION The data post-processing strategy established could greatly enhance the structural identification efficiency. The results obtained might lay the foundation for further interpretation of clinical effects, mechanism of action and quality control of MR.
Collapse
Affiliation(s)
- Jinxia Wei
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Yuanyuan Wang
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Yue Zhang
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Yanxue Zheng
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Jia Shao
- Department of Pharmacy, Tianjin First Central Hospital, Tianjin, China
| | - Wenbo Cheng
- Mass Spectrometry Application Center, Tianjin Key Laboratory of Medical Mass Spectrometry for Accurate Diagnosis, Tianjin, China
| | - Yubo Li
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| |
Collapse
|
10
|
Guo S, Yang L, Zhang Q, Zhang L, Li A. Metabolomics combined with serum pharmacochemistry discovering the potential effective compounds of Fangji Huangqi Tang against nephrotic syndrome. J Chromatogr B Analyt Technol Biomed Life Sci 2023; 1214:123532. [PMID: 36462401 DOI: 10.1016/j.jchromb.2022.123532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Revised: 10/28/2022] [Accepted: 11/03/2022] [Indexed: 11/19/2022]
Abstract
Fangji Huangqi Tang (FHT) was first recorded in "Jin Gui Yao Lue," invented by the archaic Chinese medical doctor Zhongjing Zhang, and is a classic medicine that tonifies qi and expels wind, invigorates spleen for diuresis. A large number of literatures indicated that FHT showed a significant effect on Nephrotic Syndrome (NS). A comprehensive strategy was proposed to discover the potential effective compounds and therapeutic targets of FHT against NS as a case study. Serum metabolomics combined with multivariate statistical analysis was employed to analysis and screen the differential endogenous metabolites in serum samples of the control and model rats induced by Adriamycin. The correlation analysis between the efficacy biomarkers and different compounds absorbed in serum of FHT was conducted to explore the potential effective compounds of FHT against NS. With the help of network pharmacology, the therapeutic targets and the possible molecular mechanisms of FHT against NS were further investigated. Fifteen metabolites, including l-phenylalanine, 3-Hydroxybutyric acid and linolenic acid, were associated with renal damage based on the serum metabolomic results. Metabolic pathway analysis indicated that phenylalanine, tyrosine and tryptophan biosynthesis and linoleic acid metabolism were the key pathways associated with NS. Among them, 6 metabolites were defined as efficacy biomarkers such as uric acid, 2-methylbutyrylcarnitine and 10-HDA. The results of correlation analysis suggested that 14 constituents such as fanGhinoline, cycloastragenol, atractylenolide III, and glycyrrhetinic acid were recognized as potential effective compounds, whose potential protein targets participated in the MAPK signaling pathway, GnRH signaling pathway and aldoaterone-regulated sodium reabsorption. This study has clarified the potential effective compounds and therapeutic targets of FHT against NS. The results provided new evidence for the pharmacological mechanism of FHT on NS.
Collapse
Affiliation(s)
- Songjia Guo
- Nephrology Department, Shanxi Provincial People's Hospital, Taiyuan, China
| | - Liu Yang
- Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan 030006, China; Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, China; Modern Research Center for Traditional Chinese Medicine, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, China
| | - Qingyu Zhang
- Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan 030006, China; Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, China; Modern Research Center for Traditional Chinese Medicine, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, China
| | - Lichao Zhang
- Institutes of Biomedical Sciences of Shanxi University, Taiyuan 030006, China.
| | - Aiping Li
- Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan 030006, China; Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province, China; Modern Research Center for Traditional Chinese Medicine, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University, China.
| |
Collapse
|